RuiLiMD

Oncology • Portland, OR

Physician

Join to view full profile

Dr. Li is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Li's full profile

Already have an account?

Office
4805 Ne Glisan St
Suite 6n40
Portland, OR 97213
Phone+1 503-215-5696
Is this information wrong?

Education & Training

Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
Mercy Hospital (St Louis)Residency, Internal Medicine, 2007 - 2010
Xian Medicine UniversityClass of 1996

Certifications & Licensure

OR State Medical License 2012 - 2025
NY State Medical License 2007 - 2018
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Phase I Study of Safety and Immunogenicity of ADU-623 Start of enrollment: 2014 Jan 08
Completed
Phase 1
Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma Start of enrollment: 2014 May 08
Completed
Phase 1
α-TEA in Advanced Cancer Start of enrollment: 2014 Aug 04
Completed
Phase 1
Pilot Study of DRibble Vaccine for Prostate Cancer Patients Start of enrollment: 2014 Oct 24
Completed
Phase 1
Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients Start of enrollment: 2019 Apr 03
Active, not recruiting
Phase 2
Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer Start of enrollment: 2021 Sep 10
Active, not recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

Regorafenib in Patients With Solid Tumors WithAlterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Vaibhav Sahai, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Vijay Suhag, Elie G Dib, Inderjit Mehmi, Kunal C Kadakia, Evan Pisick, Herbert L Duvivier, Phat Le...> ;JCO Precision Oncology. 2024 Apr 1
4 citations
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.
Herbert L Duvivier, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn, Tareq Al Baghdadi, Ajjai S Alva, Stephanie A Dublis, Timothy L Cannon, Carmen J...> ;Journal of Clinical Oncology. 2023 Nov 20
3 citations
Pertuzumab Plus Trastuzumab in Patients With Lung Cancer WithMutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study.
Apar K Ganti, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Elie G Dib, Herbert L Duvivier, Eugene R Ahn, Deepti Behl, Hossein Borghaei, Ani S Balmanoukian, An...> ;JCO Precision Oncology. 2023 Jun 1
5 citations
Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer WithAmplification, Overexpression, or Mutation: Results From the TAPUR Study.
Eugene R Ahn, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Hussein M Ali-Ahmad, John Chan, Michael L Maitland, Sapna R Patel, Zachary Reese, Ani S Balmanoukia...> ;JCO Precision Oncology. 2023 Apr 1
25 citations
Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial.
Tomoko Yamazaki, Andrew J Gunderson, Miranda Gilchrist, Mark Whiteford, Maria X Kiely, Amanda Hayman, David O'Brien, Rehan Ahmad, Jeffrey V Manchio, Nathaniel Fox, Kay...> ;The Lancet. Oncology. 2022 Sep 1
6 citations
Co‑ingestion of carbohydrate with branched‑chain amino acids or l‑leucine does not preferentially increase serum IGF‑1 and expression of myogenic‑related genes in resp...
Rui Li, Maria Pontes Ferreira, Matthew B. Cooke, Paul La Bounty, Bill Campbell, Mike Greenwood, Darren S Willoughby, Richard B. Kreider> ;Amino Acids. 2015 Mar 5
78 citations
Prediction of Pharmacokinetics and Drug–Drug Interactions When Hepatic Transporters are Involved
Rui Li, Hugh A. Barton, Manthena V.S. Varma> ;Clinical Pharmacokinetics. 2014 Jul 24
7 citations
Periexercise coingestion of branched-chain amino acids and carbohydrate in men does not preferentially augment resistance exercise-induced increases in phosphatidylino...
Maria Pontes Ferreira, Rui Li, Matthew B. Cooke, Richard B. Kreider, Darryn S. Willoughby> ;Nutrition Research. 2014 Mar 1
76 citations
Abiraterone Inhibits 3β-Hydroxysteroid Dehydrogenase: A Rationale for Increasing Drug Exposure in Castration-Resistant Prostate Cancer
Rui Li, Kristen Evaul, Kamalesh K. Sharma, Kai Hsiung Chang, Jennifer Yoshimoto, JJ Liu, Richard J. Auchus, Nima Sharifi> ;Clinical Cancer Research. 2012 Jul 1
12 citations
Targeting and amplification of immune killing of tumor cells by pro-Smac.
Rui Li, Dominik Rüttinger, Walter J. Urba, Bernard A. Fox, Hong-Ming Hu> ;International Journal of Cancer. 2004 Mar 10
28 citations
Analysis of the immunological microenvironment at the tumor site in patients with non-small cell lung cancer.
Rui Li, Dominik Rüttinger, Rong Li, Lü-Sheng Si, Yili Wang> ;Langenbeck's Archives of Surgery. 2003 Sep 19
Join now to see all

Lectures

Use of Diabetes Self-Management Education and Training in Persons with Newly Diagnosed Diabetes with Private Insurance in the United States, 2011
Atlanta, GA - 6/15/2014

Press Mentions

Formaldehyde-Induced Hematopoietic Stem and Progenitor Cell Toxicity in Mouse Lung and NoseOctober 21st, 2020
Histopathological Distinction of Non-Invasive and Invasive Bladder Cancers Using Machine Learning ApproachesJuly 17th, 2020